Price (delayed)
$1.49
Market cap
$8.79M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.9
Enterprise value
$7.31M
Plus Therapeutics is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company's drug development is a unique nanotechnology platform
There are no recent dividends present for PSTV.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.